FIELD: medicine, endocrinology. SUBSTANCE: invention relates to insulin-containing drug that is insulin immobilized on fresh blood erythrocytes in the presence of cross-linking agent in the ratio = 5-(10:100) in the amount of 1250-2000 U of insulin/1 g of dry mass. Method of preparing involves isolation of mammal blood erythrocytes by centrifugation, incubation of insulin with erythrocytes in the presence of cross-linking agent under condition of pendulum oscillation of mixture followed by washing out immobilized insulin with physiological solution for some cycles. In each cycle suspension is subjected for effect of centrifuge forces. Stabilizing agent is added and suspension is lyophilized. EFFECT: increased insulin content in oral medicinal form. 12 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
SOLID INSULIN-CONTAINING DRUG | 1997 |
|
RU2117488C1 |
METHOD OF PREPARING INSULIN-CONTAINING POLYMERIC HYDROGEL | 1994 |
|
RU2066551C1 |
METHOD FOR PREPARING INSULIN PREPARATION FOR ORAL USING | 2006 |
|
RU2316339C1 |
USING DERIVATIVES OF (-)-(3-TRIHALOMETHYLPHENOXY)-(4-HALOPHENYL)-ACETIC ACID IN TREATMENT OF RESISTANCE TO INSULIN, DIABETES MELLITUS TYPE II, HYPERLIPIDEMIA AND HYPERURICEMIA | 2000 |
|
RU2281762C2 |
PHARMACEUTICAL COMPOSITION AS AN MICROEMULSION WITH BIOLOGICALLY ACTIVE MACROMOLECULAR MATERIAL AND A METHOD OF ITS PREPARING | 1989 |
|
RU2122403C1 |
NEW APPLICATION OF LIVER X RECEPTOR AGONISTS | 2006 |
|
RU2417078C2 |
BIOFLAVONOIDS AS BLOOD GLUCOSE LEVEL- DECREASING AGENT | 1998 |
|
RU2203050C2 |
METHOD OF TREATMENT OF DIABETES MELLITUS OF THE SECOND TYPE AND ITS DERMAL COMPLICATIONS | 2016 |
|
RU2691641C2 |
METHOD FOR IMPROVING SIGNAL TRANSFER IN ISLETS OF LANGERHANS IN DIABETES MELLITUS AND IN ITS PROPHYLAXIS | 2001 |
|
RU2261096C2 |
POLYPEPTIDE COMPOSITION | 1999 |
|
RU2171687C2 |
Authors
Dates
2000-09-10—Published
1999-11-30—Filed